Skip to main content
SMFM 2025 Pregnancy Meeting Main banner
Final Program


Program Book
Icon Legend
Presentation Icons
Additional registration fee required
Additional registration fee required
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Recording
Recording
Poster Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared on social media
Faculty have requested this content not be shared on social media
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Back

Poster Session 1

(372) Implementation of a Novel Blood Distribution System in an Obstetrics Service

Thursday, January 30, 2025
10:30 AM – 12:30 PM  

    Submitting Author and Presenting Author(s)

  • Tobias Cohen, MD, PhD (he/him/his)

    Assistant Director of Transfusion Medicine and Cellular Biotherapies
    Weill Cornell Medicine
    NEW YORK, New York, United States

    • Coauthor(s)

  • JS

    Jaclyn Spinelli

    Blood Bank Supervisor
    New York-Presbyterian/Weill Cornell Medical Center
    New York, New York, United States

  • DC

    Dennis Chen

    IT Project Lead for Transfusion Medicine
    New York-Presbyterian/Weill Cornell Medical Center
    New York, New York, United States

  • WZ

    Wei Zeng

    Project Manager
    New York-Presbyterian/Weill Cornell Medical Center
    New York, New York, United States

  • NV

    Natali Valderrama, MSN, RN

    Patient Care Director for Labor and Delivery
    New York-Presbyterian/Weill Cornell Medical Center
    New York, New York, United States

  • PP

    Priscilla Parra, MBA

    Blood Bank Quality Assurance Supervisor
    New York-Presbyterian/Weill Cornell Medical Center
    New York, New York, United States

  • HS

    Hillary Shaw

    Vice President of Alexandra Cohen Hospital for Women & Newborns and David H. Koch Center
    New York-Presbyterian/Weill Cornell Medical Center
    New York, New York, United States

  • RK

    Robin B. Kalish, MD

    New York Presbyterian- Weill Cornell
    New York, New York, United States

  • SA

    Sharon E. Abramovitz, MD

    Associate Professor, Department of Anesthesiology
    Weill Cornell Medicine
    New York, New York, United States

  • Corrina M. Oxford-Horrey, MD

    Medical Director, Labor & Delivery
    Weill Cornell Medicine
    New York, New York, United States

  • CL

    Christine Lennon, MD

    Assistant Professor of Clinical Anesthesiology
    Weill Cornell Medicine
    New York, New York, United States

  • DB

    Denden Benabdessadek

    Blood Bank and Cellular Biotherapies Lab Manager
    New York-Presbyterian/Weill Cornell Medical Center
    New York, New York, United States

  • AJ

    Alexandra Jimenez, MD

    Associate Director of Transfusion Medicine and Cellular Biotherapies
    Weill Cornell Medicine
    New York, New York, United States

  • MC

    Melissa Cushing, MD

    Daniel M. Knowles, MD Distinguished Professor in Pathology and Laboratory Medicine
    Weill Cornell Medicine
    New York, New York, United States

  • RD

    Robert DeSimone, MD

    Director of Transfusion Medicine
    Weill Cornell Medicine
    New York, New York, United States

Objective: Obstetric hemorrhage, a leading cause of maternal morbidity and mortality, complicates up to 10% of births. Our institution opened an obstetric hospital with a satellite blood bank (SBB), 0.25 miles from the main hospital. Due to national licensed blood bank technologist shortages, the SBB could not remain open consistently, requiring blood to be obtained from the main blood bank (MBB). This presented a significant patient safety issue and increased unnecessary blood orders indicated by crossmatch-to-transfusion (C/T) ratio. Our objective was to assess the impact of implementing a novel blood distribution system using non-licensed personnel on blood product availability, ordering, and utilization.

Study Design: The BloodTrack Haemobank 80 (HB80) is an FDA-cleared smart refrigerator with 80 compartments that can perform electronic crossmatches and issue blood products (RBCs, plasma, fibrinogen concentrate, RhIG) for specific patients in a rapid and controlled manner. We developed workflows to provide 24/7 blood product dispensing and massive hemorrhage support from the HB80 using lab assistants in the SBB starting in June 2023. The SBB closure rates and C/T ratio were assessed before and after installation of the HB80.

Results: Prior to HB80 rollout, SBB experienced a high closure rate and an increasing C/T ratio (Figure 1). Post HB80, there were no unplanned SBB closures and the C/T ratio decreased from a peak 10.5 before the HB80 to a recent nadir of 4.4 after implementation (Figure 1).

Conclusion:

Implementation of a novel blood distribution system utilizing an HB80 within an obstetric unit eliminated SBB closures and improved blood product utilization. The HB80, which can be embedded within an obstetric unit, is a valuable resource to provide safe and effective blood product support for an obstetric service.